[PDF][PDF] The IDentif. AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
P Wang, APC De Hoe Chye, KTN Lim, ST Teo, YJ Tan… - scholarbank.nus.edu.sg
COVID-19 drug development has largely focused on repurposing, either through single
agent or combination therapy 1–5. To date, clinical trial outcomes of the repurposed …
agent or combination therapy 1–5. To date, clinical trial outcomes of the repurposed …